The Global Eye Allergy TreatmentMarket is expected to register CAGR of 5.30% till 2023. Some of theprotuberant drivers supporting the growth of global eye allergy treatmentmarket are identified as, increasing prevalence of ophthalmological disordersas rising aging population and changing lifestyle are promoting the risingprevalence of ophthalmological disorders. Favorable government funding by indeveloped and few developing countries in various government and privateorganizations are contributing to research and prevention programs forophthalmic disorders.
Theglobal eye allergy treatment market is expected to grow at the CAGR of ~5.2%during the forecast period and estimated to reach US$ 6845.3million by 2023.
Eyeallergies are one of the most common health problems across the globe.Approximately 50 million people have some or the other kind of eye allergy inUS alone. Some of the common eye allergy symptoms are redness, itching, andburning.
Increasingprevalence of various eye allergies are key driver for the market while someother factors like increasing awareness, technological advancements, newtherapies, and increasing healthcare expenditure are also major driving forcesof global eye allergy treatment market.
KeyPlayers for Global Eye Allergy TreatmentMarket:
Some ofthe key players in this market are:
- Johnson & Johnson Vision Care, Inc. (US),
- Merck & Co., Inc. (US),
- Pfizer Inc. (US),
- Regeneron Pharmaceuticals, Inc. (US),
- Hoffmann-La Roche Ltd (Switzerland),
- ALLERGAN (Republic of Ireland),
- Novartis AG (Switzerland),
- Santen Pharmaceutical Co., Ltd.(Japan),
- Valeant (Canada)
- Shire (Republic of Ireland), and others.
RegionalAnalysis Of Global Eye Allergy Treatment Market:
Consideringthe global scenario of the market, the Americas dominate global Eye Allergy Treatment Market Trends due tovarious factors such as large amount of money invested in R&D, newapprovals for various dugs and medicine etc. European market is second largestand is expected to grow significantly during the forecast period. Due torapidly developing healthcare facilities, rising healthcare expenditure,increasing investment in technology advancement, Asia Pacific region is thefastest growing in global eye allergy market. Middle East & Africa marketis also growing but is expected to grow slower than the global average.
SegmentationOf Global Eye Allergy Treatment Market:
On thebasis of end user, it is segmented into eye hospitals & clinics, medicalinstitutes, research centers, and others.
GlobalEye Allergy Treatment market has been segmented on the basis of type whichcomprise seasonal and perennial allergic conjunctivitis, vernalkeratoconjunctivitis, atopic keratoconjunctivitis, contact allergicconjunctivitis, giant papillary conjunctivitis, and others. Vernalkeratoconjunctivitis includes palpebral, limbal, corneal, and others.
On thebasis of treatment, the market has been segmented into medication, allergyshots (immunotherapy), and others. Medication includes artificial tears,decongestants, oral antihistamines, antihistamine/mast-cell stabilizers,corticosteroids. Decongestants are further sub-segmented into with or withoutantihistamines. Allergy shots (immunotherapy) is sub-segmented intoSubcutaneous Immunotherapy Treatment (SCIT) and Sublingual ImmunotherapyTreatment (SLIT).
BrowseComplete 76 Pages Premium Research Report Enabled with Respective Tables andFigures @ https://www.marketresearchfuture.com/reports/eye-allergy-treatment-market-3811
RELATEDREPORTS
Global Digestible Sensors Market Research Report -Forecast to 2027
Global Blood Glucose Test Strip Market ResearchReport - Forecast to 2027
Global Urology Devices Market Research Report -Forecast to 2027
About US:
MarketResearch Future (MRFR), enable customers to unravel the complexity of variousindustries through Cooked Research Report (CRR), Half-Cooked Research Reports(HCRR), Raw Research Reports (3R), Continuous-Feed Research (CFR), and MarketResearch & Consulting Services
